Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension

被引：15

作者：

Kamata, Y ^{[1
]}

Nara, H ^{[1
]}

Sato, H ^{[1
]}

Masuyama, JI ^{[1
]}

Minota, S ^{[1
]}

Yoshio, T ^{[1
]}

机构：

[1] Jichi Med Sch, Div Rheumatol & Clin Immunol, Minami Kawachi, Tochigi 3290498, Japan

来源：

关键词：

D O I：

10.1136/ard.2004.029074

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1236 / 1237

页数：2

共 9 条

[1] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension
Ghofrani, HA
Pepke-Zaba, J
Barbera, JA
Channick, R
Keogh, AM
Gomez-Sanchez, MA
Kneussl, M
Grimminger, F
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 68S - 72S
[2] Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al
Lichtenstein, JR
[J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 282 - 283
[3] MARIETTE X, 1994, J RHEUMATOL, V21, P772
[4] MORINA J, 2003, LUPUS, V12, P321
[5] Nishimaki T, 1999, J RHEUMATOL, V26, P2357
[6] Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the Raynaud phenomenon
Rosenkranz, S
Diet, F
Karasch, T
Weihrauch, J
Wassermann, K
Erdmann, E
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) : 871 - 873
[7] Sanchez O, 2003, PRESSE MED, V32, P789
[8] TOJO T, 1996, ANN REP RES COMMITTE, P3
[9] YOSHIO T, 1994, J RHEUMATOL, V21, P2058